Brevan Howard Capital Management »

Verve Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 15k 13.94

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf (HYG)
Consumer Staples Spdr Sbi Cons Stpls (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Health Care Select Secto Sbi Healthcare Call Option (XLV)
Ishares Jp Morgan Usd Emerging Markets Jpmorgan Ud Emg (EMB)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
KraneShares CSI China Internet ETF Csi Chi Internet (KWEB)
Ishares Ftse/xinhua China 25 China Lg-cap Etf (FXI)
Ishares Msci Eafe Index Fund Msci Eafe Etf Put Option (EFA)
Ishares Msci Brazil Msci Brazil Etf (EWZ)
Kbw Regional Banking Etf S&p Regl Bkg Call Option (KRE)
Vnet 0 02/26 Note 2/0 (Principal)

View all positions for Brevan Howard Capital Management

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics